Flash Finance

Aristo Bio-Tech And Lifescience LimitedARISTOCorporate

Pesticides / Agrochemicals - Indian Latest results: Mar 2026 9 quarters of data
₹94.00
MCap ₹64 Cr · P/E 9.1
Aristo Bio-Tech And Lifescience Limited — Stock analysis & AI research Aristo Bio-Tech And Lifescience Limited — Seasonality — best & worst months Aristo Bio-Tech And Lifescience Limited — Live exchange announcements
🏭 Chemicals sector
AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.
₹107 Cr
Sales · Mar 2026
+2.9% YoY
₹8 Cr
Operating Profit · Mar 2026
+700.0% YoY
7.5%
OPM % · Mar 2026
+650.0% YoY
₹3 Cr
Net Profit · Mar 2026
₹4.42
EPS · Mar 2026
+713.9% YoY

📝 Aristo Bio-Tech And Lifescience Limited — results explained

Quarter ended March 2026 (Q4 FY26)

Aristo Bio-Tech And Lifescience Limited reported revenue of ₹107 crore for the quarter ended March 2026 (Q4 FY26), up 2.9% from ₹104 crore in the same quarter last year.

Net profit stood at ₹3 crore. Earnings per share (EPS) came in at ₹4.42.

Operating profit stood at ₹8 crore — an operating margin (OPM) of 7.5%, compared with 1.0% in the year-ago quarter.

Full year and trailing twelve months

On a trailing-twelve-month (TTM) basis, revenue stands at ₹363 crore with a net profit of ₹7 crore.

Valuation snapshot

At the current price of ₹94.00, ARISTO has a market capitalisation of ₹64 crore and a trailing P/E of about 9.1.

Within the Pesticides / Agrochemicals - Indian industry, it is the 19th-largest of the 19 companies we track by market value.

Shareholding pattern

As of Mar 2026, promoters held 73.42%, public shareholders 26.58% of Aristo Bio-Tech And Lifescience Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close
Valuation
Market Cap ?
₹64 Cr
Current Price ?
₹94.0
P/E ?
9.14below ind
Industry P/E ?
17.40
P/B ?
1.42
P/S ?
0.18
P/FCF ?
12.80
Enterprise Value ?
₹99 Cr
EV/EBITDA ?
6.19
PEG ?
0.35
Earnings Yield ?
14.1%
Dividend Yield ?
0.53%
Profitability & Returns
Sales (TTM) ?
₹363 Cr
OPM ?
4.4%
Profit after tax (TTM) ?
₹7 Cr
EPS (TTM) ?
₹10.28
ROCE ?
20.0%
ROE ?
15.6%
ROA ?
4.5%
Growth
Sales — latest qtr ?
₹107 Cr
PAT — latest qtr ?
₹3 Cr
YoY qtr sales growth ?
2.9%
YoY qtr profit growth ?
N/A
Sales growth (3y) ?
19%
Sales growth (5y) ?
17%
Profit growth (3y) ?
26%
Profit growth (5y) ?
46%
Financial Health
Debt ?
₹35 Cr
Debt to Equity ?
0.78
Interest Coverage ?
N/A
Current Ratio ?
N/A
Ownership
Promoter holding ?
73.42%
Change in promoter holding ?
0.05%
Pledged percentage ?
N/A
Market
Return 3 months ?
-1.2%
Return 6 months ?
9.7%

🗓️ Quarterly results (9 quarters · ₹ Cr)

same fiscal quarter as Mar bestweakest per row · for costs (interest, NPAs) low is best
Metric Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026 YoY % QoQ %
Sales 7312989133112214104256107 +2.9% —
Operating Profit 154538188 +700.0% —
Other Income 000000000 — —
Interest 112111113 +200.0% —
Depreciation 111111111 +0.0% —
Profit Before Tax -141426-164 +500.0% —
Net Profit 031315043 — —
EPS -0.483.801.473.781.946.68-0.726.134.42 +713.9% —
OPM % 1.4% 3.9% 4.5% 3.8% 2.7% 3.7% 1.0% 3.1% 7.5% +650.0% —

📆 Annual results (₹ Cr, FY = Apr–Mar)

Annual rollup not yet available We need at least 3 quarters of a fiscal year to compute annual figures. This symbol does not yet have a complete fiscal year in our database.

🏛️ Balance Sheet (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Equity Capital 7777 +0.0%
Reserves 23273138 +22.6%
Borrowings 22212235 +59.1%
Other Liabilities 47738175 -7.4%
Total Liabilities 100127141155 +9.9%
Fixed Assets 16222424 +0.0%
CWIP 1000 —
Investments 0000 —
Other Assets 83106117131 +12.0%
Total Assets 100127141155 +9.9%

💧 Cash Flow (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Cash from Operating Activity -38108 -20.0%
Cash from Investing Activity -4-7-5-3 +40.0%
Cash from Financing Activity 8-2-4-4 +0.0%
Net Cash Flow 1-102 —
Free Cash Flow -7155 +0.0%
CFO/OP -17%106%123%69% -43.9%

➗ Ratios (latest 4 periods)

Metric Mar 2023Mar 2024Mar 2025Mar 2026 % Chg
Debtor Days 75866555 -15.4%
Inventory Days 57655970 +18.6%
Days Payable 851129778 -19.6%
Cash Conversion Cycle 48382646 +76.9%
Working Capital Days 36312225 +13.6%
ROCE % 16%13%12%20% +66.7%

👥 Shareholding (latest 4 periods)

Metric Sep 2024Mar 2025Sep 2025Mar 2026 % Chg
Promoters 73.37%73.42%73.42%73.42% +0.0%
Public 26.63%26.58%26.58%26.58% +0.0%
No. of Shareholders 625512468453 -3.2%

⚖️ Peer comparison

Industry: Pesticides / Agrochemicals - Indian · 19 companies · full page →
# Company CMP MCap (Cr) P/E Sales TTM NP TTM OPM% NPM% Sales YoY% NP YoY% Qtr Rev Δ% Qtr NP Δ%
1 SHARDACROP Sharda Cropchem ₹725.00 6,541 10.4 5,357 626 19.5% 11.7% 21.9% 123.7% 9.0% -38.4%
2 DHANUKA Dhanuka Agritech ₹961.85 4,288 16.4 1,978 265 19.6% 13.4% -24.5% -36.2% -7.9% -27.3%
3 RALLIS Rallis India ₹198.12 3,853 — — — — — 7.2% -28.4% — —
4 NACLIND NACL Industries ₹136.70 3,202 279.0 1,519 12 7.0% 0.8% 28.3% 105.0% -14.5% 59.8%
5 BHAGCHEM Bhagiradha Chemicals ₹244.25 3,167 115.2 607 28 13.0% 4.5% 21.7% 31.1% 57.6% 235.0%
6 BHARATRAS Bharat Rasayan ₹1,157.40 1,924 13.4 1,203 143 14.6% 11.9% 5.9% 3.3% -10.4% -6.1%
7 INSECTICID Insecticides (India) ₹608.95 1,772 14.2 2,060 125 10.1% 6.1% 7.0% -1.2% -11.5% -24.5%
8 IPL India Pesticides ₹134.99 1,555 14.4 1,033 108 15.9% 10.5% 27.5% 44.4% -8.5% -34.8%
9 ASTEC Astec LifeSciences ₹696.90 1,553 — 441 -67 1.3% -15.1% 17.5% 39.9% -8.3% 43.4%
10 MOL Meghmani Organics ₹57.90 1,472 22.9 2,103 64 9.9% 3.1% 4.5% 371.1% -11.5% 280.0%
11 PUNJABCHEM Punjab Chemicals ₹1,037.20 1,272 19.4 1,058 65 11.8% 6.2% 14.4% 64.3% 8.7% 7.0%
12 EXCELINDUS Excel Industries ₹966.80 1,215 17.0 1,079 71 10.2% 6.6% 11.9% -12.0% -5.1% -12.7%
13 DHARMAJ Dharmaj Crop ₹269.40 910 15.1 1,155 60 9.3% 5.2% 22.5% 91.4% 4.6% 16.8%
14 BESTAGRO Best Agrolife ₹18.99 674 22.6 1,272 30 10.4% 2.3% -30.7% -87.1% 4.0% 103.2%
15 HERANBA Heranba Industries ₹167.20 669 — 1,525 -77 5.7% -5.0% 13.1% -3549.1% -15.3% 11.2%
16 SHIVALIK Shivalik Rasayan ₹350.80 562 38.3 375 20 12.3% 5.2% 18.0% -12.0% 7.9% 59.5%
17 SIKKO Sikko Industries ₹5.85 256 41.9 65 6 12.0% 9.4% 2.3% 109.7% -2.3% 43.4%
18 CLSL Crop Life ₹48.35 83 12.6 207 7 8.2% 3.4% — — -7.4% 33.3%
19 ARISTO Aristo Bio-Tech ₹89.15 61 8.5 363 7 4.4% 1.9% — — 2.9% —
❓ Frequently asked questions
What was Aristo Bio-Tech And Lifescience Limited's revenue in Q4 FY26?
Aristo Bio-Tech And Lifescience Limited reported revenue of ₹107 crore for the quarter ended March 2026 (Q4 FY26), up 2.9% from ₹104 crore in the same quarter last year.
What was Aristo Bio-Tech And Lifescience Limited's net profit in Q4 FY26?
Net profit stood at ₹3 crore. Earnings per share (EPS) came in at ₹4.42.
What is ARISTO's market capitalisation and P/E ratio?
At the current price of ₹94.00, ARISTO has a market capitalisation of ₹64 crore and a trailing P/E of about 9.1.
Who owns Aristo Bio-Tech And Lifescience Limited? (shareholding pattern)
As of Mar 2026, promoters held 73.42%, public shareholders 26.58% of Aristo Bio-Tech And Lifescience Limited.
TTM ends 2026-03-31. Amounts are ₹ crore unless stated otherwise. Figures are extracted by AI from public quarterly filings; gaps are filled from public market data. Live price refreshed about twice a day from exchange data. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI